Pharmaceutical Investing XTANDI® Plus Leuprolide Significantly Improves Survival Outcomes in Men with Non-Metastatic Hormone-Sensitive Prostate Cancer with High-Risk Biochemical Recurrence 10 July
Pharmaceutical Investing Pfizer Invites Public to View and Listen to Webcast of August 5 Conference Call with Analysts 25 June
